Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7373
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas ; day:29 ; month:12 ; year:2022 ; pages:1-8
Journal of neuro-oncology ; (29.12.2022), 1-8
- Urheber
-
Wollring, Michael M.
Werner, Jan-Michael
Ceccon, Garry
Lohmann, Philipp
Filss, Christian P.
Fink, Gereon R.
Langen, Karl-Josef
Galldiks, Norbert
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11060-022-04218-x
- URN
-
urn:nbn:de:101:1-2023031021074782843537
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wollring, Michael M.
- Werner, Jan-Michael
- Ceccon, Garry
- Lohmann, Philipp
- Filss, Christian P.
- Fink, Gereon R.
- Langen, Karl-Josef
- Galldiks, Norbert
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
Therapies for IDH-Mutant Gliomas
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Proteomic Exploration of IDH-Mutant Gliomas using Mass Spectrometry
Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas
Predicting IDH genotype in gliomas using FET PET radiomics
Determinants of long-term survival in patients with IDH-mutant gliomas
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas
Altered metabolic landscape in IDH ‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
Methylation class oligosarcoma may encompass IDH-wildtype gliomas
Partial erosion on under-methylated regions and chromatin reprogramming contribute to oncogene activation in IDH mutant gliomas
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
Therapies for IDH-Mutant Gliomas
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Proteomic Exploration of IDH-Mutant Gliomas using Mass Spectrometry
Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas
Predicting IDH genotype in gliomas using FET PET radiomics
Determinants of long-term survival in patients with IDH-mutant gliomas
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas
Altered metabolic landscape in IDH ‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
Methylation class oligosarcoma may encompass IDH-wildtype gliomas
Partial erosion on under-methylated regions and chromatin reprogramming contribute to oncogene activation in IDH mutant gliomas
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
Therapies for IDH-Mutant Gliomas
Stalled oligodendrocyte differentiation in IDH-mutant gliomas
Proteomic Exploration of IDH-Mutant Gliomas using Mass Spectrometry
Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas
Predicting IDH genotype in gliomas using FET PET radiomics
Determinants of long-term survival in patients with IDH-mutant gliomas
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas
Altered metabolic landscape in IDH ‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
Methylation class oligosarcoma may encompass IDH-wildtype gliomas